Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2015 1
2016 1
2017 4
2018 1
2020 4
2021 3
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Strongyloides stercoralis in the US Military Health System.
Taheri B, Kuo HC, Hockenbury N, Lu D, Mitre E, Hickey PW. Taheri B, et al. Among authors: kuo hc. Open Forum Infect Dis. 2023 Mar 18;10(3):ofad127. doi: 10.1093/ofid/ofad127. eCollection 2023 Mar. Open Forum Infect Dis. 2023. PMID: 37008572 Free PMC article.
Prognostic features of Annexin A2 expression in prostate cancer.
Tan SH, Young D, Chen Y, Kuo HC, Srinivasan A, Dobi A, Petrovics G, Cullen J, Mcleod DG, Rosner IL, Srivastava S, Sesterhenn IA. Tan SH, et al. Among authors: kuo hc. Pathology. 2021 Feb;53(2):205-213. doi: 10.1016/j.pathol.2020.07.006. Epub 2020 Sep 20. Pathology. 2021. PMID: 32967771 Free PMC article.
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.
Oehrlein N, Streicher SA, Kuo HC, Chaurasia A, McFadden J, Nousome D, Chen Y, Stroup SP, Musser J, Brand T, Porter C, Rosner IL, Chesnut GT, Onofaro KC, Rebbeck TR, D'Amico A, Lu-Yao G, Cullen J. Oehrlein N, et al. Among authors: kuo hc. Cancer Med. 2022 Nov;11(22):4354-4365. doi: 10.1002/cam4.4787. Epub 2022 May 31. Cancer Med. 2022. PMID: 35638719 Free PMC article.
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression.
Gesztes W, Schafer C, Young D, Fox J, Jiang J, Chen Y, Kuo HC, Mwamukonda KB, Dobi A, Burke AP, Moul JW, McLeod DG, Rosner IL, Petrovics G, Tan SH, Cullen J, Srivastava S, Sesterhenn IA. Gesztes W, et al. Among authors: kuo hc. Sci Rep. 2022 Mar 30;12(1):5404. doi: 10.1038/s41598-022-08826-5. Sci Rep. 2022. PMID: 35354846 Free PMC article.
Race, tumor location, and disease progression among low-risk prostate cancer patients.
Mygatt JG, Cullen J, Streicher SA, Kuo HC, Chen Y, Young D, Gesztes W, Williams G, Conti G, Porter C, Stroup SP, Rice KR, Rosner IL, Burke A, Sesterhenn I. Mygatt JG, et al. Among authors: kuo hc. Cancer Med. 2020 Mar;9(6):2235-2242. doi: 10.1002/cam4.2864. Epub 2020 Jan 21. Cancer Med. 2020. PMID: 31965751 Free PMC article.
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017.
Stroup SP, Robertson AH, Onofaro KC, Santomauro MG, Rocco NR, Kuo HC, Chaurasia AR, Streicher S, Nousome D, Brand TC, Musser JE, Porter CR, Rosner IL, Chesnut GT, D'Amico A, Lu-Yao G, Cullen J. Stroup SP, et al. Among authors: kuo hc. Cancer Med. 2022 Dec;11(24):4756-4766. doi: 10.1002/cam4.4802. Epub 2022 May 26. Cancer Med. 2022. PMID: 35616266 Free PMC article.
21 results